Insider: LAROSA JOSEPH J EVP General Counsel and Secret - REGENERON PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 37,937 | 0 | 37,937 |
| Value | $21,158,603.01 | $0.00 | $21,158,603.01 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 07/11/2024 | DDS | 1,866 | Direct | COM | $1,088.95 | $2,031,980.70 | 37,937 |
| 05/21/2024 | DDS | 1,865 | Direct | COM | $994.90 | $1,855,488.50 | 34,678 |
| 02/26/2024 | DDS | 1,000 | Direct | COM | $990.00 | $990,000.00 | 36,543 |
| 02/22/2024 | DDS | 1,000 | Direct | COM | $967.65 | $967,650.00 | 37,543 |
| 02/07/2024 | DDS | 1,000 | Direct | COM | $950.00 | $950,000.00 | 38,543 |
| 04/07/2022 | DDS | 5,114 | Direct | COM | $721.10 | $3,687,705.40 | 16,900 |
| 08/23/2021 | DDS | 41 | Direct | COM | $665.40 | $27,281.40 | 13,183 |
| 08/23/2021 | DDS | 3,383 | Direct | COM | $661.80 | $2,238,869.40 | 13,224 |
| 08/23/2021 | DDS | 1 | Direct | COM | $666.22 | $666.22 | 13,182 |
| 07/06/2021 | DDS | 3,398 | Direct | COM | $580.00 | $1,970,840.00 | 13,182 |
| 08/31/2020 | DDS | 4,672 | Direct | COM | $615.04 | $2,873,466.88 | 14,438 |
| 05/15/2020 | DDS | 8,380 | Direct | COM | $572.00 | $4,793,360.00 | 14,438 |
| 04/20/2020 | DDS | 112 | Direct | COM | $571.65 | $64,024.80 | 15,076 |
| 04/20/2020 | DDS | 61 | Direct | COM | $572.94 | $34,949.34 | 15,015 |
| 04/20/2020 | DDS | 669 | Direct | COM | $567.30 | $379,523.70 | 15,547 |
| 04/20/2020 | DDS | 577 | Direct | COM | $573.59 | $330,961.43 | 14,438 |
| 04/20/2020 | DDS | 234 | Direct | COM | $569.41 | $133,241.94 | 15,313 |
| 04/20/2020 | DDS | 125 | Direct | COM | $570.27 | $71,283.75 | 15,188 |
| 04/20/2020 | DDS | 416 | Direct | COM | $563.58 | $234,449.28 | 19,250 |
| 04/20/2020 | DDS | 51 | Direct | COM | $561.57 | $28,640.07 | 19,687 |
| 04/20/2020 | DDS | 1,468 | Direct | COM | $565.60 | $830,300.80 | 17,405 |
| 04/20/2020 | DDS | 1,189 | Direct | COM | $566.44 | $673,497.16 | 16,216 |
| 04/20/2020 | DDS | 21 | Direct | COM | $562.71 | $11,816.91 | 19,666 |
| 04/20/2020 | DDS | 377 | Direct | COM | $564.74 | $212,906.98 | 18,873 |
| 04/17/2020 | DDS | 6 | Direct | COM | $550.00 | $3,300.00 | 16,300 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research